FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 128 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,855,000 | -17.4% | 133,272 | -6.2% | 0.07% | -18.0% |
| Q2 2018 | $2,247,000 | +59.7% | 142,154 | +74.3% | 0.09% | +56.1% |
| Q1 2018 | $1,407,000 | +7.4% | 81,546 | +36.4% | 0.06% | -3.4% |
| Q4 2017 | $1,310,000 | -21.5% | 59,767 | +46.6% | 0.06% | -34.4% |
| Q3 2017 | $1,668,000 | -36.8% | 40,773 | -53.5% | 0.09% | -58.7% |
| Q2 2017 | $2,638,000 | +12.8% | 87,609 | +35.5% | 0.22% | -6.0% |
| Q1 2017 | $2,338,000 | -28.8% | 64,669 | -1.3% | 0.23% | -41.9% |
| Q4 2016 | $3,284,000 | -4.6% | 65,541 | -0.0% | 0.40% | -12.7% |
| Q3 2016 | $3,441,000 | +400.9% | 65,550 | +294.5% | 0.46% | +371.1% |
| Q2 2016 | $687,000 | -52.1% | 16,615 | -52.9% | 0.10% | +10.2% |
| Q1 2016 | $1,434,000 | +82.9% | 35,296 | +86.9% | 0.09% | -11.1% |
| Q4 2015 | $784,000 | – | 18,884 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|